![](/img/cover-not-exists.png)
Cost-Effectiveness and Cost-Utility of Intralesional Recombinant Human Epidermal Growth Factor for Adjuvant Treatment of Wagner’s 3 and 4 Diabetic Foot Ulcers
Romero Prada, ME, Vivas-Consuelo, D, Huerfano, LM, Alfonso Quiñones, PA, Roa Cardenas, NC, Acero, GVolume:
19
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2016.09.1880
Date:
November, 2016
File:
PDF, 90 KB
english, 2016